Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.11
+0.06 (0.99%)
At close: Oct 14, 2024, 4:00 PM
6.00
-0.11 (-1.79%)
After-hours: Oct 14, 2024, 5:38 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $235.82 million as of October 14, 2024. Its market cap has increased by 372.58% in one year.
Market Cap
235.82M
Enterprise Value
70.85M
1-Year Change
372.58%
Ranking
Category
Stock Price
$6.11
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $235.82M, a decrease of -68.73%. That is a compound annual growth rate of -15.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 233.50M | 88.46% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 241.69M |
| Mersana Therapeutics | 241.67M |
| ModivCare | 237.38M |
| Enanta Pharmaceuticals | 233.92M |
| Sera Prognostics | 233.58M |
| Delcath Systems | 233.11M |
| SOPHiA GENETICS | 232.39M |
| ProKidney | 230.67M |